Synergistic effects of ceftazidime/avibactam combined with meropenem in a murine model of infection with KPC-producing Klebsiella pneumoniae.

Mei ZhengFu-Hao LiJuan LiuWen-Jie LiRuo-Xi YinDa-Tong CaiDiego O AndreySi-Lin ZhengAna Cristina Gales Wan-Jiang Zhang Jian SunXiao-Ping LiaoYang Yu

Published in: The Journal of antimicrobial chemotherapy (2024)

Our results indicated that the combination of ceftazidime/avibactam plus meropenem offers viable therapeutic alternatives in treating serious infections due to KPC-Kp.

Keyphrases

klebsiella pneumoniae
gram negative
multidrug resistant
escherichia coli
cancer therapy